Product information

From Health Canada

Current status:

Cancelled Pre Market

Current status date:

2015-10-16

Original market date: See footnote 1

Product name:

RATIO-NAPROXEN E

DIN:

02231006 Electronic product monograph is not available

Company:

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Tablet (Enteric-Coated)

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

28:08.04.92 

Anatomical Therapeutic Chemical (ATC): See footnote 4

M01AE02 NAPROXEN

Active ingredient group (AIG) number:See footnote5

0109634003

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
NAPROXEN 500 MG
Version 4.0.3

"Page details"

Date modified: